You have 9 free searches left this month | for more free features.

Condition

Hepatocellular Carcinoma (HCC) (1)

Solid Tumors (1)

Overall Status

Completed (1)

Recruiting (1)

Sign in for free

Phase

phase 1 (2)

Sponsor

Chugai Pharmaceutical (2)

Collaborator

Intervention

ery974 (2)

atezolizumab (1)

bevacizumab (1)

tocilicumab (1)

Study Documents

Intervention Type

drug (2)

Funder Type

Industry (2)

Study Type

Interventional (2)

ery974

Showing 1 - 2 of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Hepatocellular Carcinoma (HCC) Trial in Japan, Taiwan (ERY974, Tocilicumab, Atezolizumab)

Recruiting

Hepatocellular Carcinoma (HCC)

ERY974
+3 more

Chiba-shi, Chiba, Japan
+5 more

Jun 22, 2022

Solid Tumors Trial in France, Netherlands, United States (ERY974)

Completed

Solid Tumors

ERY974

Washington, District of Columbia
+9 more

Aug 21, 2019